Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:47 PM
Ignite Modification Date:
2025-12-24 @ 7:47 PM
NCT ID:
NCT02816203
Eligibility Criteria:
Inclusion Criteria:
* women between 18 and 45 years old
* patient under loco-regional anesthesia
* patient who presents primary postpartum hemorrhage (blood loss ≥ 500ml) after a vaginal childbirth requiring administration of Nalador®.
* affiliation to the French social security system or equivalent
* patient who has signed a consent to participate
Exclusion Criteria:
* patient with a uterine malformation
* patient allergic to silicon
* patient under general anesthesia
* patient who delivered via caesarean section
* patient with fever or suspected infection during labor
* person deprived of freedom by judicial or administrative decision
* person hospitalized without their consent
* person under legal protection
* person hospitalized for psychiatric care
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT02816203
Study Brief:
Protocol Section:
NCT02816203